英文论文投稿信

第一篇：英文论文投稿信

英文论文投稿信模板

Case 1

Dear Editor,We would like to submit the enclosed manuscript entitled “GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons”, which we wish to be considered for publication in Nature Neuroscience.GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease.In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices.Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase.Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF.Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release.These results may also have implications in the treatment of Parkinson’s disease.Due to a direct competition and conflict of interest, we request that Drs.XXX of Harvard Univ., and YY of Yale Univ.not be considered as reviewers.With thanks for your consideration, I am

Sincerely yours,case2

Dear Editor,We would like to submit the enclosed manuscript entitled “Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release”, which we wish to be considered for publication in Neuron.We believe that two aspects of this manuscript will make it interesting to general readers of Neuron.First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses.This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission.Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin.Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx.Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor.Our findings may also have general implications in the cell biology of neurotransmitter release.[0630][投稿写作]某杂志给出的标准Sample Cover Letter[the example used is the IJEB]

Case 3

Sample Cover Letter[the example used is the IJEB]

Dear Editor of the [please type in journal title or acronym]:

Enclosed is a paper, entitled “Mobile Agents for Network Management.” Please accept it as a candidate for publication in the [journal title].Below are our responses to your submission requirements.1.Title and the central theme of the article.Paper title: “Mobile Agents for Network Management.” This study reviews the concepts of mobile agents and distributed network management system.It proposes a mobile agent-based implementation framework and creates a prototype system to demonstrate the superior performance of a mobile agent-based network over the conventional client-server architecture in a large network environment.2.Which subject/theme of the Journal the material fits

New enabling technologies(if no matching subject/theme, enter 'Subject highly related to [subject of journal] but not listed by [please type in journal title or acronym])

3.Why the material is important in its field and why the material should be published in [please type in journal title or acronym]?

The necessity of having an effective computer network is rapidly growing alongside the implementation of information technology.Finding an appropriate network management system

has become increasingly important today's distributed environment.However, the conventional centralized architecture, which routinely requests the status information of local units by the central server, is not sufficient to manage the growing requests.Recently, a new framework that uses mobile

agent technology to assist the distributed management has emerged.The mobile agent reduces network traffic, distributes management tasks, and improves operational performance.Given today's bandwidth demand over the Internet, it is important for the [journal title/acronym] readers

to understand this technology and its benefits.This study gives a real-life example of how to use mobile agents for distributed network management.It is the first in the literature that reports the analysis of network performance based on an operational prototype of mobile agent-based distributed

network.We strongly believe the contribution of this study warrants its publication in the [journal title/acronym].4.Names, addresses, and email addresses of four expert referees.Prof.Dr.William Gates

Chair Professor of Information Technology

321 Johnson Hall

Premier University Lancaster, NY 00012-6666, USA

phone: +1-888-888-8888fax: +61-8-8888-8886

e-mail: jadams@au.edu.au

Expertise: published a related paper(“Creating Mobile Agents”

Relationship: None.I have never met Dr.Adams.Assoc Prof.Dr.Chia-Ho Chen

Chair of MIS Department

College of Management

Open University

888, Putong Road

Keelung, Taiwan 100

phone: +886-2-8888-8888fax: +852-8888-8886

e-mail: fyoung@abcc.com

Expertise: Mr.Young provides consulting services extensively to his clients regarding network management practices.Relationship: I have worked with Mr.Young in several consulting projects in the past three years.Finally, this paper is our original unpublished work and it has not been submitted to any other journal for reviews.Sincerely,Johnny Smithin IJ Electronic Business, 1(4), pp.in IEEE TOSE, 18(8), pp.88-98.

第二篇：怎样写英文投稿信

Dear Prof.XXXXX,Here within enclosed is our paper for consideration to be published on “(Journal name)”.The further nformation about the paper is in the following:

The Title: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

The Authors: XXXXXXXXXX XXXXXXXXXXXX and XXXXXXXXXX

The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.I am the corresponding author and my address and other information is asfollows,Address: Department of XXXXXXXXX,Tsinghua University,Beijing, 10084,P.R.China

E-mail: XXXXX@mail.tsinghua.edu.cn

Tel: 86-10-62785001

Fax: 86-10-62785001

Thank you very much for consideration!

Sincerely Yours,Dr.XXXXXXXXXXX

投稿信举例：

Dear Dr．：

Enclosed are three copies of a manuscript by Rose N ．Dipaola，Donna A．Gallo，and Tom N．Roberts titled“Hepatitis C Virus Infection in Long-Term Transfusion Patients”．It is submitted to be considered for publication as a“Original Article" in your journal．This paper is～•Neither the entire paper nor any part of its content has been published or has been accepted elsewhere ．It is not being submitted to any other journal．

We believe the paper may be of particular interest to the readers of your journal because the study it reports stated the HCV infection rate among long-term transfusion patients is higher than that of the general population and of short-term transfusion patients．

Correspondence and phone calls about the paper should be directed to Rose N．Dipaola at the following address，phone and fax number，and e-mail address：

Rose N ．Dipaola，MD

Institute of Internal Medicine

Cleveland Clinic Foundation

9500 Euclid Ave．

Cleveland，OH44195，USA

Tel：1-216-444-5360

Fax：1-216-444-9580

E-mail：dipao＠cesmtp ．ccf.Org

Thanks very much for your attention to our paper．

Sincerely yours，Rose N．Dipaola

修改稿

Dear Editor,We are pleased to answer the questions of the reviewers’ and the manuscript(Manuscript number…)has also been extensively revised

according to the comments(resubmitted online).Question #1:

Answer:

Question #2:

Answer:

Best wishes,Sincerely yours,Name

第三篇：英文投稿信的客套话

英文投稿信的客套话

一、投稿信

往国外杂志投稿,就是写COVER LETTER,主要内容应该有: 简述所投稿件的核心内容、主要发现和意义，拟投期刊，对稿件处理有无特殊要求等（如“not to review” list）。另外，请附上主要作者的中文姓名、通讯地址、电话、传真和e-mail地址。此外有的杂志要求推荐几位审稿人及其联系方式。以及谁已经阅读过该文（当然是牛人）。最后给一个模板: Dear Dr.主编name: We submit our manuscript entitled “ 文章title” to 杂志名for publication.接着简单介绍你文章的主要创新点和意义，不易过多，但要突出新意和关键点。All authors have seen the manuscript and approved to submit to your journal.Thank you very much for your attention and consideration.Sincerely yours, 通讯作者

[search]投稿信[/search]

1.Dear Dr.Defendi ML: I am sending a manuscript entitled “” by – which I should like to submit for possible publication in the journal of.We have chosen this journal because it deals with.6.Please ask someone familiar with English language to help you rewrite this paper.As you will see, I have made some correction at the beginning of the paper where some syntax is not satisfactory.7.We feel that this potentially interesting study has been marred by an inability to communicate the finding correctly in English and should like to suggest that the authors seek the advice of someone with a good knowledge of English, preferable native speaker.8.The wording and style of some section, particularly those concerning HPLC, need careful editing.Attention should be paid to the wording of those parts of the Discussion of and Summary which have been underlined.9.Preliminary experiments only have been done and with exception of that summarized in Table 2, none has been repeated.This is clearly unsatisfactory, particularly when there is so much variation between assays.10.The condition of incubation are poorly defined.What is the temperature? Were antibody used?

五、给编辑的回信

1.In reply to the referee’s main criticism of paper, it is possible to say that –

One minor point raised by the referee concerns of the extra composition of the reaction mixture in Figure 1.This has now been corrected.Further minor changes had been made on page 3, paragraph 1(line 3-8)and 2(line 6-11).These do not affect our interpretation of the result.2.I have read the referee’s comments very carefully and conclude that the paper has been rejected on the sole grounds that it lake toxicity data.I admit that I did not include a toxicity table in my article although perhaps I should have done.This was for the sake of brevity rather than an error or omission.3.Thank you for your letter of – and for the referee’s comments concerning our manuscript entitled “”.We have studied their comments carefully and have made correction which we hope meet with their approval.4.I enclosed a revised manuscript which includes a report of additional experiments done at the referee’s suggestion.You will see that our original findings are confirmed.5.We are sending the revised manuscript according to the comments of the reviewers.Revised portion are underlined in red.6.We found the referee’s comments most helpful and have revised the manuscript 7.We are pleased to note the favorable comments of reviewers in their opening sentence.8.Thank you for your letter.I am very pleased to learn that our manuscript is acceptable for publication in Cancer Research with minor revision.9.We have therefore completed a further series of experiments, the result of which are summarized in Table 5.From this we conclude that intrinsic factor is not account.10.We deleted the relevant passage since they are not essential to the contents of the paper.11.I feel that the reviewer’s comments concerning Figures 1 and 2 result from a misinterpretation of the data.12.We would have include a non-protein inhibitor in our system, as a control, if one had been available.13.We prefer to retain the use of Table 4 for reasons that it should be clear from the new paragraph inserted at the end of the Results section.14.Although reviewer does not consider it is important to measure the temperature of the cells, we consider it essential.15.The running title has been changed to “”.16.The Materials and Methods section now includes details for measuring uptake of isotope and assaying hexokinase.17.The concentration of HAT media(page12 paragraph 2)was incorrectly stated in the original manuscript.This has been rectified.The authors are grateful to the referees for pointing out their error.18.As suggested by both referees, a discussion of the possibility of laser action on chromosome has been included(page16, paragraph 2).19.We included a new set of photographs with better definition than those originally submitted and to which a scale has been added.20.Following the suggestion of the referees, we have redraw Figure 3 and 4.21.Two further papers, published since our original submission, have been added to the text and Reference section.These are: 22.We should like to thank the referees for their helpful comments and hope that we have now produced a more balance and better account of our work.We trust that the revised manuscript is acceptable for publication.23.I greatly appreciate both your help and that of the referees concerning improvement to this paper.I hope that the revised manuscript is now suitable for publication.24.I should like to express my appreciation to you and the referees for suggesting how to improve our paper.25.I apologize for the delay in revising the manuscript.This was due to our doing an additional experiment, as suggested by referees

第四篇：英文论文投稿及修改流程

SCI投稿过程总结、投稿状态解析、拒稿后处理对策及接受后期相关问答综合荟萃目录（重点是一、二、四、五、六）：

（一）投稿前准备工作和需要注意的事项、投稿过程相关经验总结

（二）SCI期刊投稿各种状态详解及实例综合（学习各种投稿状态+投稿经历总结）

（三）问答综合篇（是否催稿、如何撤稿、一稿两投及学术不端相关内容等）

（四）如何处理审稿意见（回复意见、补实验、润色、重整数据、作图及调整、申辩及其他）

（五）Reject 或者Reject and resubmit后的对策和处理

（六）稿件接受后期的相关问题（作者信息、地址版权、单行本、彩图费、版面费、如何汇款、清样相关等）

（七）进阶篇（如何选投SCI杂志、各专业方向期刊选择、SCI写作经验）

（一）投稿前准备工作和需要注意的事项、投稿过程相关经验总结

投稿前准备工作和需要注意的事项：

总结提示语：

1)第一作者和通信作者的区别：

通信作者（Corresponding author)通常是实际统筹处理投稿和承担答复审稿意见等工作的主导者，也常是稿件所涉及研究工作的负责人。

通信作者的姓名多位列于论文作者名单的最后（使用符号来标识说明是Corresponding author)，但其贡献不亚于论文的第一作者。

通讯作者往往指课题的总负责人，负责与编辑部的一切通信联系和接受读者的咨询等。

文章的成果是属于通讯作者的，说明思路是通讯作者的，而不是第一作者。

第一作者仅代表是你做的，且是最主要的参与者！

通信作者标注名称：Corresponding author，To whom correspondence should be addressed,或 The person to whom inquiries regarding the paper should be addressed

若两个以上的作者在地位上是相同的，可以采取“共同第一作者”（joint first author)的署名方式，并说明These authors contributed equally to the work。2)作者地址的标署：

尽可能地给出详细通讯地址，邮政编码。有二位或多位作者，则每一不同的地址应按之中出现的先后顺序列出，并以相应上标符号的形式列出与相应作者的关系。

如果第一作者不是通讯作者，作者应该按期刊的相关规定表达，并提前告诉编辑。期刊大部分以星号（*）、脚注或者致谢形式标注通讯联系人。3)挑选审稿人的几个途径：

很多SCI杂志都需要作者自己提出该篇论文的和您研究领域相关的审稿人，比较常见的是三名左右，也有的杂志要求5-8人。介绍几个方法：

①利用SCI、SSCI、A&HCI、ISTP检索和您研究相关的科学家；

②文章中的参考文献；

③相关期刊编委或学术会议的主席、委员；

④以前发表的类似文章的审稿人；

⑤询问比较熟识的一些专业人士；

⑥交叉审稿，邀请以前的作者；

⑦若是团队序贯研究，斟酌考虑自建期刊审稿人专家库。

PS: 如果有熟悉的同领域的专家，可以推荐一两位为宜（若你全部推荐熟人也无可厚非，但编辑基本不会全部考虑，可能对你还有点特殊“眼色”了）。考虑推荐自己文章的参考文献作者较为常用，当然，如果你是负面引用的话，务必慎重了。4)重视审稿人较为关注的问题，对照修改自己的稿件最后定稿

①有的审稿人特别重视是否有比较明确的假说和意义凸显点存在（我之前投shock有位审稿人就是抓住这个不放，重投杯具原因之一就在于此）；

②论证是否合乎逻辑，讨论和结论是否合理；

③参考文献引用是否妥当；

④内容是否新颖、重要；

⑤文字表达是否正确、简明、清楚；

⑥实验描述部分是否清楚并且能被读者重复、实验数据是否真实、可靠；

⑦论题是否适合于相应的期刊；

⑧图表的使用和设计是否必要、规范、清楚；

⑨摘要、引言、体例是否合适。5)合理应用一些小技巧：

①了解所投杂志刊登文章的主要方向，投其所好；

②阅读目标期刊的征稿说明，按要求逐一修改；

③参考文献要有1-2篇来自该期刊或者审稿人；

④请在该期刊发表过较多文章的同行或朋友修改一下文章。

6)稿件及其相关材料准备：Manuscript.doc、Tables.doc、Figures（多大多数杂志要求tiff格式，少数可接受jpg等）、Cover letter，有时还有Title page、Copyright agreement、Conflicts of interest等

（二）SCI期刊投稿各种状态详解及实例综合（学习各种投稿状态+投稿经历总结）

1.Submitted to Journal 刚提交的状态——新手请看这里！！

一般的步骤是这样的：网上投稿-Submit a manuscript：先到每个杂志的首页，打开submit paper一栏，先以通讯作者的身份register一个账号，然后以author login身份登录，按照提示依次完成：Select Article Type、Enter Title、Add/Edit/Remove Authors、Submit Abstract、Enter Keywords、Select Classifications、Enter Comments、Request Editor、Attach Files，最后下载pdf，查看无误后，即可到投稿主页approve submission或直接submit it。

总结提示语：对于投稿之前和提交确认投稿过程，这里还需要对投稿新手强调以下几点。因为这些小问题被编辑评个低印象分不划算，被打回也浪费了时间和精力。一条条说来：

1)大多数系统是要求word投稿正文内容的，pdf多不为接受格式。但也有很少数要求用pdf格式的，务必注意细看稿约。

2)文献格式是否按拟投杂志标准要求核准？有的投稿系统是可以直接检查的。

3)引用文献条数是否符合该杂志要求？有的杂志不特别要求，有的还是非常重视的。如我之前投shock杂志，编辑和一位审稿人都提到参考文献不要超过35条。如果你文章写完后，能够适当精简文献条数，那么，请删减几条吧。

4)很多系统要求勾选同意一些如伦理道德的声明文件

5)提交后可能会有一个小栏目提示对提交图片的质量做了初步审查（不合格的最好重新作图再上传）

6)绝大多数投稿完成后需要view submission和最后确认（approve submission）。view submission 就是要求你再整体看看投稿填写的这些资料信息+cover letter+正文+图片表格，所生成的pdf全文是否满意、合格，也是你投稿完成前最后一次检查的机会了。

PS：有的新手可能不注意这点，提交后就不管了，还开开心心以为自己投稿成功，殊不知结果邮箱里一直没有收到投稿后的邮件回执和稿号，直到最后纳闷几天了才回去看系统状态。

2.Manuscript received by Editorial Office文章到了编辑手里了，证明投稿成功

3.With editor 若投稿时未要求选择编辑，则先到主编处，主编会分派给副主编或者其他编辑。这当中就会有另两个状态：

I)Awaiting Editor Assignment指派责任编辑

II)Editor assigned是把你的文章分给一个编辑处理了。

III)Editor Declined Invitation 如果编辑接手处理了就会邀请审稿人了。

总结提示语：一般情况下，投稿（submit）状态后一个星期内会出现编辑处理稿件（with editor）这个状态。很多老外编辑很不能理解中国人喜欢催稿，绝大多数情况下，他们不会像国内某些期刊一样能拖上一年半载再给屁大点修回意见。要适当给编辑一点时间处理，他们也很忙的。不要轻易催稿，也有人因为催稿而立马收到杯具消息——不知是编辑不耐烦了，还是一种巧合。当然，如果submit四个星期后网上投稿系统还没出现with editor状态信息，就要询问主编了，要注意委婉用语。不过要注意，也有期刊没有with editor状态。

4.with editor后送审可能有的2种状态（Decision Letter Being Prepared或Reviewers invited）：

总结提示语：Ⅰ)Decision Letter Being Prepared 就是编辑没找审稿人就自己决定了，一般而言此时很危险。一可能是英文太差，需要语言润色。二可能是内容太差。除非被大牛们直接接收。

Ⅱ)Reviewer(s)invited 找到审稿人了，就开始审稿

5.Under review 此过程的等待较为漫长。当然之前各步骤也可能很慢，要看编辑的处理情况。

总结提示语：这个过程也不要轻易催稿，一般都是已邀请审稿人和已送审等过程中。如果被邀请审稿人不想审，就会decline，编辑会重新邀请别的审稿人。我之前一篇SCI投inflammation research 初审就用了四个半月，而且还是中途催稿两次。之后小修两次，不符审稿人口味，8个月杯具了，那时心情万分沉重难受。

6.Required Reviews Completed 表示审稿意见已经返回给编辑。

总结提示语：这个状态大多情况下不会持续太久，几小时到几天为多，基本上根据最初投稿后分配的稿件编号数量可以预测到这个过程的处理时间。稍安勿躁，安心等待吧。

7.Evaluating Recommendation 评估审稿人的意见，随后你将收到编辑给你的decision

8.Decision in process 等待稿件处理意见

总结提示语：这时候应该全部审稿人意见回来了，编辑开始斟酌意见、处理稿件。有的稿子评价都很好，一般都很快就决定accept或者小修；有的稿件审稿评价均很差，则无一例外会reject；

值得重视的是：相当一部分情况是等待时间一周以上的，多是由于审稿人意见不统一，有好有坏，这时候编辑可能会自己决定此文章的命运，可能充分尊重审稿人意见而拒稿（这种情况处理也很快的），可能编委会讨论决定是再修（major revision可能性较大，否则就直接Reject），也可能会找一位审稿人。这时要根据不同的状态而出现等待时间不一了。

9.Minor revision/Major revision 小修或大修。至此问题一般不会太大，充分尊重审稿人和编辑的意见。

总结提示语：能有条件就尽量补实验，是在不行就认真考虑理由申辩，但谦虚谨慎的语气必不可少。毕竟大修的也存在一定的拒稿率，而小修的绝大多数是能够最后搞定的。10.Revision Submitted to Journal 又开始了一个循环。11.Accepted 接受（这是最开心的时候了）

目前需要做的事有：

1）.享受accept后的小幸福和快乐

2）.了解稿件接受后期的其他相关问题主要有：作者信息和地址的准确性、版权转让、校样proof、单行本、版面费等。注意了解本帖之

（六）“稿件接受后期的其他相关问题 ”内容。

3）.动态关注邮箱情况，注意查收邮件，编辑会要求尽快完善copyright transfer agreement的，后面的工作就会转给出版商了。清样proof的时间不定，短的一两周，长的半年都有，但一般情况下都是4~6周左右。后面还会陆续提及版面费（若你所投期刊免版面费除外）、彩图费、单行本等问题。

4）.最最后重要的一件事——在论文版分享你进行课题设计、完成实验，以及写作与投稿中的经验收获。

12.reject（将在后面推出专栏、专楼或另外专贴谈谈拒稿后如何处理的专题篇）

总结提示语：这里就不必多说了。对于我们广大的硕士博士研究生而言，绝大多数人是有着杯具经历的，那种心情大多体会过，一定要振奋精神。希望大家整理好心情，重新上路。13.其他相对少见的、or细分的状态(期待大家补充)：

Initial QC Started： QC=quality control, Initial QC Started就是说编辑刚开始初审，还没有提交给审稿人。

这个是编辑部会有个对文章格式、附图等的检查，等着就行了。如果有问题他们会联系你的，关注邮箱或系统吧。pending

如投稿后editor assigment pending 等待责任编辑处理

审稿后decision pending 目前已外审结束，等待编辑决定（写评论意见ing）

（三）问答综合篇（是否催稿、如何撤稿、一稿两投及学术不端相关内容等）

总结提示语：①何时可询问状态？也即如何催稿？

一般来说，根据这个杂志通常审稿周期来定。具体审稿周期不建议询问，但可以参考一些投稿系统和公司的查询网页，当然最好的办法还是上DXY求助。写信一定要委婉，否则你的催稿信就可能成拒稿信了。

②关于撤稿——投稿本身就是一件很严肃的事情，撤稿则相当不严肃。实际上，撤稿，除非极特殊的原因，是很坏的行为。不能把稿子发现问题，要重新修改等作为撤稿的借口。你每次投稿，以及相关的行为和结果，都是有记录的。撤稿会严重影响你们课题组的credit。最后导致你们组的稿件会受到特殊“照顾”，可能你以后不投那个杂志了，但可能对今后的师弟师妹投稿造成不良影响。

（四）如何处理审稿意见（补实验、语言润色、重整数据、回复、统计方法、生存率作图、申辩、版面费和彩图费减免，及其他）

如何回复审稿人意见~~总结提示语：

①所有问题必须逐条回答。

②尽量满足意见中需要补充的实验。

③满足不了的也不要回避，说明不能做的合理理由。

④审稿人推荐的文献一定要引用，并讨论透彻。

一般而言，审稿人提出要补充的实验，如果不是非做不可的，还是可以进行解释。有时审稿人即使想接受你的文章，总还要提出一些不足之处。如果你真的不想补充实验或者补充很困难，可以合理的解释，一般没问题的。最重要的是逐条回答，老实交代。绝大部分实验是不要真追加的，除非你受到启发，而想该投另外高档杂志。

⑤修回后投稿一定要核对初稿中改正的地方：作者的一般信息和各种联系方式、标题、摘要、图片编号、数据值、cover letter等。版权协议和利益冲突表格要谨慎填写。签名时尽量不要代签。

对于要求增补实验的问题~~总结提示语

（1）审稿人要求用其他细胞、造模方式、实验技术进一步验证的问题。

回复对策：

1.如果实验难度不大，建议尽量补充。

2.如果实验不可能重新再做一遍，不可能全部换个造模方式把动物再杀一道，经费和时间不允许重来.....eg：

1）.指出你文章中所用的细胞是本研究所主要关注的，目前已研内容可基本证明研究目的和问题所在，说明.....2）.如果找到相关的文献依据（近年份、分数稍高于你所投杂志）也只是用了某一种细胞，会更好。

3）.务必十分感谢审稿人的意见，我们将遵从您的指导，在后继研究中继续探讨，用其他细胞进一步验证结论，并与目前的研究进行对比，继续投稿。

另外，需要注意的是——揣摩审稿人的态度强硬程度，其他审稿人的好评程度，编辑的倾向性。如果总体是好评，其他审稿人和编辑也倾向于修，那么尽量往小补实验+论辩思路走。

倘若审稿人主要是刁难，编辑也不太看好本文，那么还是要尽全力补充实验，毕竟补了后发表机会会更大些，人家审稿也会看你的修稿态度的。

关于版面费和彩图费~~总结提示语：

关于版面费，有的杂志可以在接收后申请减免，有的杂志必须在投稿时附信中即有希望能申请减免版面费的说明，如EBM（experimental biology and medicine）杂志。

相当一部分杂志不收版面费，但是可能要收彩图费。文章投稿过程用的彩图，accept后转给出版商处理，会有邮件就发表相关事宜进行商量，如清样proof有无问题？彩图费多少及如何交付？是否需要将彩图转成黑白图？订购单行本offprint的数量？是否开放获取open access？由于诸多科研工作者获取全文都是通过在线阅读pdf文献，而那些订阅纸质版的读者对你的文章图片十分感兴趣的话，也可以通过网上数据库获取，以进一步了解。由于彩图的电子版免费，纸质版收费。故对于彩图费的问题，你完全可以跟出版商如是说明“我们选择电子版用彩图，纸质版用黑白图”。此过程不影响文章接收和发表，不必担心。

（五）Reject 或者reject & resubmit后的对策和处理。

审稿人直接给出意见，或者几位审稿人意见不统一，编辑可能直接拒稿reject，或者处理为拒稿可重投（Reject and resubmit）。

总结提示语：如果是reject了，那么就只能改投别的杂志了。当然也不能盲目投稿，如果还期待投个IF比较合意的杂志，那么还是要认真考虑审稿人的拒稿意见，针对修改。

而如果是reject & resubmit，相当于是给了次机会再修改投稿，务必珍惜。

一定要充分考虑是否能达到全部审稿人的所有要求，尤其是对待那个别持反对、尖锐意见的审稿人。

要根据意见逐一修改所有问题，否则此番再投，审稿人还是会觉得没有达到其期望值和满意度，文章必然凶多吉少。我先前投过shock（五年来IF在2.87~3.5之间），经历有些坎坷，是重投后三位审稿人通过两位（有位审稿人纠缠初投时提出的两点意见不放，认为我的回答和修改不满意），编辑拒掉了。当然，如果觉得难度较大，初投被拒可重投时就果断地另外考虑其他杂志投算了。

第五篇：投稿信

投 稿 信

尊敬的编辑先生/女士：

您好！

本人受所有作者委托，在此提交完整的论文《 基于改进粒子群优化算法和混沌神经网络的电力系统负荷预测》，希望能够在《电网技术》杂志发表，并且代表所有作者郑重申明：（1）关于该论文，所有作者均已通读并同意投往贵刊，对作者排序没有异议，不存在利益冲突及署名纠纷；（2）论文成果属于原创，享有自主知识产权，不涉及保密问题；（3）相关内容未曾以任何语种在国内外公开发表过，没有一稿多投行为；（4）今后关于论文内容及作者的任何修改，均由本人负责通知其他作者知晓。

本人对上述各项负完全责任。论文的主要内容简介：

本文提出了一种基于改进粒子群算法和混沌神经网络相结合的电力系统负荷预测的方法。针对传统的粒子群算法精度低、易发散等缺点，同时采用线性递减惯性权重和压缩因子，结合遗传算法交叉变异对其进行改进。利用粒子群优化算法优化出混沌神经网络的权值和阈值，然后利用得到的权值和阈值，对输入神经网络的负荷值进行预测，得到预测日的相应时刻负荷值。最后通过实际应用，采用MATLAB编程实现预测模型，证明该方法有较高的预测精度和较好的准确性，具备一定的实际应用价值。本论文的创新点在于：

（1）提出了一种改进粒子群算法和混沌神经网络相结合的负荷预测方法；

（2）同时采用线性递减惯性权重和压缩因子，结合遗传算法交叉变异对传统的粒子群算法进行改进，克服了其精度低、易发散等缺点；

（3）利用混沌神经网络对日负荷进行预测，采用MATLAB仿真实现。

鉴于论文的内容。。。（论文的内容负荷贵刊物的要求，并且论文的研究成果具有一定的应用价值。）

下面是推荐的几个审稿专家，谨供参考。1）姓名，E-mail：。2）姓名，E-mail：。

非常感谢您审阅本论文，期待早日收到专家的审查意见。若对于本论文有任何疑问，请及时与我联系。遵照《中华人民共和国著作权法》，作者同意将该文版权（含各种介质的版权）转让给《电网技术》编辑部。编辑部一次性向作者付清稿酬。

此致

敬礼！

投稿人：王冰山

身份证号： ***831 所有作者姓名： 王冰山 出生年 ：1988 学历 ：硕士研究生 职称：无

研究方向： 电力系统自动化及计算机信息处理、分布式电源等联系电话：*** E-mail：wbshan1216@163.com

，